Immunogenetic of ankylosing spondylitis;Immunogénétique de la spondylarthrite ankylosante

Revue de Medecine Interne

Volumn 27, Issue 10, 2006, Pages 762-771

  Toussirot, E ^a   Wendling, D ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Ankylosing spondylitis; Heavy chain homodimers; HLA B27; Immunogenetic

Indexed keywords

AMINO ACID; BACTERIAL ANTIGEN; BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; HOMODIMER; PEPTIDE; TOLL LIKE RECEPTOR;

AMINO ACID SEQUENCE; ANKYLOSING SPONDYLITIS; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; BIOCHEMISTRY; BIOLOGICAL TRAIT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHROMOSOME ANALYSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FAMILIAL DISEASE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEAVY CHAIN; IMMUNE RESPONSE; IMMUNOGENETICS; INFLAMMATION; INNATE IMMUNITY; LIGHT CHAIN; MACROPHAGE; NEUTROPHIL; NONHUMAN; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PROTEIN DETERMINATION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; SHORT SURVEY; SIBLING; SYNOVITIS; T LYMPHOCYTE ACTIVATION; TRANSGENIC ANIMAL; TWINS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; HLA-B27 ANTIGEN; HUMANS; PEDIGREE; PEPTIDES; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749150113     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.05.005     Document Type: Short Survey

References (66)

1. Breban M. La spondylarthrite. Introduction. In: Breban (Ed). La spondylarthrite (2004), John Libbey Eurotext, Montrouge 3-7
2. Le Parc J.M. Manifestations rhumatismales de la spondylarthrite. In: Breban (Ed). La spondylarthrite (2004), John Libbey Eurotext, Montrouge 43-54
3. Saraux A., Guillemin F., Guggenbuhl P., Roux C.H., Fardellone P., Le Bihan E., et al. Prevalence of spondylarthropathies in France: 2001. Ann. Rheum. Dis. 64 (2005) 1431-1435
4. Hacquard C., and Breban M. Physiopathologie de la spondylarthrite. In: Breban (Ed). La spondylarthrite (2004), John Libbey Eurotext, Montrouge 17-42
5. Laloux L., Voisin M.C., Allain J., Martin N., Kerboull, Chevalier X., et al. Immunohistological study of entheses in spondylarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann. Rheum. Dis. 60 (2001) 316-321
6. Baeten D., Demetter P., Cuvelier C., Van Den Bosch F., Kruithof E., Van Damme N., et al. Comparative study of the synovial histology in rheumatoid arthritis, spondylarthropathy, and osteoarthritis: influence of disease duration and activity. Ann. Rheum. Dis. 59 (2000) 945-953
7. Drouart M., Saas P., Billot M., Cedoz J.P., Tiberghien P., Wendling D., et al. High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin. Exp. Immunol. 132 (2003) 158-162
8. Baeten D., Kruithof E., De Rycke L., Boots A.M., Mielants H., Veys E., et al. Infiltration of the synovial membrane with macrophages and polymorphonuclear cells reflects global disease activity of spondylarthropathy. Arthritis Res. Ther. 7 (2005) R359-R369
9. Braun J., Bollow M., Neure L., Seipelt E., Seyrekbasan F., Herbst H., et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 38 (1995) 499-505
10. Reveille J.D., Ball E.J., and Khan M.A. HLA-B27 and genetic predisposing factors in spondylarthropathies. Curr. Opin. Rheumatol. 13 (2001) 265-272
11. Reveille J.D., and Arnett F.C. Spondylarthritis: update on pathogenesis and management. Am. J. Med. 118 (2005) 592-603
12. Said-Nahal R., Miceli-Richard C., Berthelot J.M., Duche A., Dernis-Labous E., Le Blevec G., et al. The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe français d'étude génétique des spondylarthropathies. Arthritis Rheum. 43 (2000) 1356-1365
13. Said-Nahal R., Miceli-Richard C., D'Agostino M.A., Dernis-Labous E., Berthelot J.M., Duche A., et al. Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum. 45 (2001) 478-484
14. Said-Nahal R., Miceli-Richard C., Gautreau C., Tamouza R., Borot N., Porcher R., et al. The role of HLA genes in familial spondylarthropathy: a comprehensive study of 70 multiplex families. Ann. Rheum. Dis. 61 (2002) 201-206
15. Porcher R., Said-Nahal R., D'Agostino M.A., Miceli-Richard C., Dougados M., and Breban M. Two major spondylarthropathy phenotypes are distinguished by pattern analysis in multiplex families. Arthritis Rheum. 53 (2005) 263-271
16. Breban M., Said-Nahal R., Hugot J.P., and Miceli-Richard C. Familial and genetic aspects of spondylarthropathy. Rheum. Dis. Clin. North Am. 29 (2003) 575-594
17. Brown M.A., Kenendy L.G., MacGregor A.J., Darke C., Duncan E., Shatford J.L., et al. Susceptibility to ankylosing spondylitis in twins. The role of genes, HLA and the environment. Arthritis Rheum. 40 (1997) 1823-1828
18. Brewerton D.A., Caffrey M., Hart F.D., James D.C.O., Nichols A., and Sturrock R.D. Ankylosing spondylitis and HL-A27. Lancet i (1973) 904-907
19. Ball E.J., and Khan M.A. HLA-B27 polymorphism. Joint Bone Spine 68 (2001) 378-382
20. Wordsworth P., and Brown M. HLA-B27, ankylosing spondylitis and the spondylarthropathies. In: Calin A., and Taurog J.D. (Eds). The spondylarthritides (1998), Oxford University Press, Oxford 179-193
21. Monowarul Islam S.M., Numaga J., Fujino Y., Masuda K., Ohda H., Hirata R., et al. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum. 38 (1995) 547-550
22. Laval S.H., Timms A., Edwards S., Bradbury L., Brophy S., Milicic A., et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic susceptibility. Am. J. Hum. Genet. 68 (2001) 918-926
23. Zhang G., Luo J., Bruckel J., Weisman M.A., Schumacher H.R., Khan M.A., et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum. 50 (2004) 2246-2254
24. Miceli-Richard C., Zouali H., Said-Nahal R., Lesage S., Merlin F., De Toma C., et al. Significant linkage to spondylarthropathy on 9q31-34. Hum. Mol. Genet. 13 (2004) 1641-1648
25. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., and Song G.G. Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J. Hum. Genet. 50 (2005) 453-459
26. Miceli-Richard C., Zouali H., Lesage S., Thomas G., Hugot J.P., Said-Nahal R., et al. CARD15/NOD2 analysis in spondylarthropathy. Arthritis Rheum. 46 (2002) 1405-1406
27. Crane A.M., Bradbury L., Van Heel D.A., McGovern D.P.B., Brophy S., Rubin L., et al. Role of NOD2 variants in spondylarthritis. Arthritis Rheum. 46 (2002) 1629-1633
28. Feirreiros-Vidal I., Amarelo J., Barros F., Carracedo A., Gomez-Reino J.J., and Gonzalez A. Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease. J. Rheumatol. 30 (2003) 102-104
29. Hamersma J., Cardon L.R., Bradbury L., Brophy S., Van der Horst-Bruinsma I., Calin A., et al. Is disease severity in ankylosing spondylitis genetically determined?. Arthritis Rheum. 44 (2001) 1396-1400
30. Bownes P. HLA B27 in health and disease: a double-edged sword. Rheumatol. 41 (2002) 857-868
31. Lopez de Castro J.A. The pathogenic role of HLA-B27 in chronic arthritis. Curr. Opin. Immunol. 10 (1998) 59-66
32. Allen R.L., Bownes P., and McMichael J. The role of HLA-B27 in spondylarthritis. Immunogenetics 50 (1999) 220-227
33. McMichael J., and Bownes P. HLA-B27: natural function and pathogenic role in spondylarthritis. Arthritis Res. 4 Suppl 3 (2002) S153-S158
34. Madden D.R., Gorga J.C., Strominger J.L., and Wiley D.C. The structure of HLA B27 reveals nonamer self peptides bound in an extended conformation. Nature 353 (1991) 321-325
35. Jardetsky T.S., Lane W.S., Robinson R.A., Madden D.R., and Wiley D.C. Identification of self peptides bound to purified HLA-B27. Nature 353 (1991) 326-329
36. Allen R.L., O'Callaghan C.A., McMichael A.J., and Bowness P. Cutting edge: HLA-B27 can form a novel β2-microglobulin free heavy chain homodimer structure. J. Immunol. 162 (1999) 5045-5048
37. Mear J.P., Schreiber K.L., Munz C., Zhu X., Stevanovic S., Rammensee H.G., et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondylarthropathies. J. Immunol. 163 (1999) 6665-6670
38. Hammer R.E., Maika S.D., Richardson J.A., Tang J.P., and Taurog J.D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: an animal model of HLA-B27 associated disorder. Cell 63 (1990) 1099-1112
39. Taurog J.D. Animal models of the spondylarthropathies. In: Calin A., and Taurog J.D. (Eds). The spondylarthritides (1998), Oxford University Press, Oxford 223-237
40. Breban M., Hammer R.E., Richardson J.A., and Taurog J.D. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftement. J. Exp. Med. 178 (1993) 1607-1616
41. Taurog J.D., Richardson J.A., Croft J.T., Simmons W.A., Zhou M., Fernandez-Sueiro J.L., et al. The germ-free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180 (1994) 2359-2364
42. Tran T.L., Dorris M.L., Satumtira N., Richardson J., and Taurog J.D. Additional human beta-2m curbs HLA-B27 heavy chain misfolding and promotes arthritis and spondylitis but not colitis in male B27 transgenic rats. Arthritis Rheum. 52 Suppl (2005) S447-S448
43. Khare S.D., Luthra H.S., and David C.S. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2 microglobulin: a model of human spondylarthropathies. J. Exp. Med. 182 (1995) 1153-1158
44. Sieper J., Braun J., Wu P., and Kingsley G. T cells are responsible for the enhanced synovial cellular immune response to triggering antigen in reactive arthritis. Clin. Exp. Immunol. 91 (1993) 96-102
45. Hermann E., Yu D.T.Y., Zum Buschenfelde K.H.M., and Fleischer B. HLA-B27 restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342 (1993) 646-650
46. Sieper J., and Braun J. Triggering mechanisms and T cell responses in the spondylarthropathies. In: Calin A., and Taurog J.D. (Eds). The spondylarthritides (1998), Oxford University Press, Oxford 195-206
47. Boyle L.H., Goodall J.C., Opat S.S., and Gaston J.S. The recognition of HLA-B27 by human CD4+ T lymphocytes. J. Immunol. 167 (2001) 2619-2624
48. Cao D., Van Vollenhoven R., Klareskog L., Trollmo C., and Malmstrom V. CD25 bright CD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. (2004) R335-R346
49. Rudwaleit M., and Höhler T. Cytokine gene polymorphisms relevant for the spondylarthropathies. Curr. Opin. Rheumatol. 13 (2001) 250-254
50. Berthelot J.M., Glémarec J., Guillot P., Laborie Y., and Maugars Y. New pathogenic hypotheses for spondyloarthropathies. Joint Bone Spine 69 (2002) 114-122
51. Urban R.G., Chicz R.M., Lane W.S., Strominger J.L., Rehm A., Kenter M.J.H., et al. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. Natl. Acad. Sci. USA 91 (1994) 1534-1538
52. Atagunduz P., Appel H., Kuon W., Wu P., Thiel A., Kloetzel P.M., et al. HLA-B27 restricted CD8+ T cell response to cartilage derived self peptides in ankylosing spondylitis. Arthritis Rheum. 52 (2005) 892-901
53. Fiorillo M.T., Maragno M., Butler R., Dupuis M.L., and Sorrentino R. CD8+ T cell autoreactivity to an HLA B27 restricted self epitope correlates with ankylosing spondylitis. J. Clin. Invest. 106 (2000) 47-53
54. Fiorillo M.T., Ruckert C., Hulsmeyer M., Sorrentino R., Saenger W., Ziegler A., et al. Allele dependent similarity between viral and self peptide presentation by HLA-B27 subtypes. J. Biol. Chem. 280 (2005) 2962-2971
55. Ruckert C., Fiorillo M.T., Loll B., Moretti R., Biesiadka J., Saenger W., et al. Conformational dimorphism of self peptides and molecular mimicry in a disease associated HLA B27 subtype. J. Biol. Chem. 281 (2006) 2306-2316
56. Lahesmaa R., Skurnik M., Gransfors K., Mottonen T., Saario T., Toivanen A., et al. Molecular mimicry in the pathogenesis of spondylarthropathies. A critical appraisal of cross reactivity between microbial antigens and HLA-B27. Br. J. Rheumatol. 31 (1992) 221-229
57. Schwimmbeck P.L., Yu D.T., and Oldstone M.B. Autoantibodies to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter syndrome. Molecular mimicry with Klebsellia pneumoniae as potential mechanism of autoimmune disease. J. Exp. Med. 166 (1987) 161-173
58. Kapasi K., and Inmann R.D. HLA-B27 expression modulates Gram negative bacterial invasion into transfected L cells. J. Immunol. 148 (1992) 3554-3559
59. Virtala M., Salmi M., Pelliniemi L.J., Yu D.T., and Granfors K. HLA-B27 modulates intracellular survival of Salmonella enteriditis in human monocytic cells. Eur. J. Immunol. 27 (1997) 1331-1338
60. Dangoria N.S., DeLay M.L., Kingsbury D.J., Mear J.P., Uchanska-Ziegler B., et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J. Biol. Chem. 277 (2002) 23459-23468
61. Turner M.J., Sowders D.P., DeLay M.L., Mohapatra R., Bai S., Smith J.A., et al. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J. Immunol. 175 (2005) 2438-2448
62. Toussirot E., Saas P., Pariset J., Chabod J., Tiberghien P., and Wendling D. Decreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondylarthropathies. Ann. Rheum. Dis. 65 (2006) 279-280
63. Allen R.L., and Trowsdale J. Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors. Curr. Mol. Med. 4 (2004) 59-65
64. Pachebo-Tena C., Zhang X., Stone M., Burgos-Vargas R., and Inman R. Innate immunity in host-microbial interactions: beyond B27 in the spondylarthropathies. Curr. Opin. Rheumatol. 14 (2002) 373-382
65. De Rycke L., Vandooren B., Kruithof E., De Keyser F., Veys E., and Baeten D. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-Like receptor 2 and Toll-like receptor 4 in spondylarthropathy. Arthritis Rheum. 52 (2005) 2146-2158
66. Van Der Paardt M., Crusius J.B.A., De Koning M.H.M.T., Morré S.A., Van de Stadt R.J., Dijkmans B.A.C., et al. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 64 (2005) 235-238